The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that ...

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...

CNN wellness expert Dr. Leana Wen suggests what to do to reduce your risk of catching respiratory viruses this winter and how to treat them if you’re sick.

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

AI Optics, a biotech startup backed by NYU Langone and raising in stealth, announced clearance this week from the Food and ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...